Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Abbisko Therapeutics

Request full access

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development

Pudong, ChinaFounded 2016Biotech & Life Sciences

About Abbisko Therapeutics

Abbisko Therapeutics is a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative small molecule therapies for oncology. Founded in 2016 and based in the Zhangjiang Hi-Tech Park in Shanghai, China, the company leverages a robust in-house R&D engine and a multi-dimensional discovery platform to advance its pipeline of 10 small molecule programs. Abbisko serves the oncology market, targeting unmet medical needs with differentiated therapies. The business model focuses on taking drug candidates from discovery through clinical development and commercialization, generating revenue through partnerships, licensing agreements, and eventual product sales. The company is led by a seasoned management team with extensive experience in drug discovery and development, ensuring a strategic approach to bringing new treatments to market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Pudong, China
Employees
49
Open positions
2
Dealroom signal
72.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Oct 2021 $226M $1.1B Undisclosed —
SERIES DOther financing Jan 2021 $123M $492M Warburg Pincus · CICC · Sage Partners · The Carlyle Group —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Abbisko Therapeutics website traffic

Latest recorded traffic for Abbisko Therapeutics is 3.9K monthly website visits, up 200% over the last three months. Abbisko Therapeutics's team declined 3.9% over the past year.

Latest monthly visits3.9K 3-month web change+200% 1-year team growth-3.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Amygdala NeuroscienceAmygdala's mission is to address the growing unmet need associated with substance use disorder by discovering, developing and commercializing safe and effective pharmacotherapies to treat and prevent addiction Palo Alto, United States Operational 3 $7.6M —
Beckley PsytechClinical-stage biotechnology developing rapid-acting psychedelic medicines Beckley and Stowood, United Kingdom Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
Rosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology Bristol, United Kingdom Operational
EmpiricoHuge biological datasets, human genetics, and programmable biology to power novel target discovery and development San Diego, United States Operational
BraeburnBraeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid addiction Washington DC, United States Operational
PredxBioTissue-Based Decision Intelligence for Oncology Bellevue, United States Operational
BiofourmisBiotechnology company that augments personalized care and therapies using digital therapeutics Boston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Abbisko Therapeutics in the Pudong ecosystem

Live from Dealroom

The Abbisko Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later9 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Abbisko Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Abbisko Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.